New! Sign up for our free email newsletter.
Science News
from research organizations

Chronic obstructive pulmonary disease caused 3.2 million deaths worldwide in 2015

Date:
August 16, 2017
Source:
The Lancet
Summary:
Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study. COPD is a group of lung conditions (including emphysema and chronic bronchitis) that cause breathing difficulties.
Share:
FULL STORY

Latest global estimates illustrate the vast impact of the two most common chronic respiratory diseases, with 3.2 million deaths from chronic obstructive pulmonary disease (COPD) and 0.4 million deaths caused by asthma in 2015, according to a new Global Burden of Disease study published in The Lancet Respiratory Medicine journal.

COPD is a group of lung conditions (including emphysema and chronic bronchitis) that cause breathing difficulties. The condition is largely caused by smoking and air pollution.

The study finds that asthma is the most common chronic respiratory disease worldwide, with twice the number of cases of COPD in 2015, but that deaths from COPD were eight times more common than deaths from asthma. Many cases of asthma and COPD can be treated or prevented with affordable interventions, but people are often left undiagnosed, misdiagnosed or undertreated.

The study estimates the number of cases and deaths caused by the two diseases between 1990 and 2015. While overall prevalence and death rates have reduced since 1990, population growth and the ageing population mean that the numbers have increased. The number of deaths from COPD increased by 11.6% between 1990 and 2015 (from 2.8 to 3.2 million deaths), and the number of cases increased by 44.2% (from 121 to 174.5 million cases). Comparatively, deaths from asthma reduced by 26.2% (from 0.55 to 0.4 million deaths) but prevalence increased by 12.6% (from 318.2 to 358.2 million) over the same time period.

"COPD and asthma contribute substantially to the burden of non-communicable disease. Although much of the burden is either preventable or treatable with affordable interventions, these diseases have received less attention than other prominent non-communicable diseases like cardiovascular disease, cancer, or diabetes," says lead author Professor Theo Vos, Institute of Health Metrics and Evaluation, University of Washington, USA. "Up-to-date information on COPD and asthma is key to policy making to improve access to and quality of existing interventions."

As a result of the larger number of cases, there were more people living with disability -- with the countries with the highest burden of disability from COPD and asthma typically residing in developing regions.

Disease burden due to COPD in 2015 was highest in Papua New Guinea, India, Lesotho, and Nepal, and burden for asthma was highest in Afghanistan, Central African Republic, Fiji, Kiribati, Lesotho, Papua New Guinea, and Swaziland.

The lowest COPD disease burden was seen in some countries in high-income Asia Pacific, central Europe, north Africa and the Middle East, the Caribbean, western Europe, and Andean Latin America, and the lowest asthma disease burden was seen in countries in eastern and central Europe, plus China, Italy, and Japan.

The main risk factors for COPD were smoking and air pollution, followed by household air pollution, occupational risk (such as asbestos, diesel fumes, arsenic and benzene), ozone and second-hand smoke, leading the authors to call for public health interventions to reduce air pollution and further reduce global smoking rates.

Conversely, the causes of asthma are less clear, but include smoking and asthma-causing allergens experienced in the workplace.

The authors highlight the need for more research into causes of COPD and asthma to create better prevention measures and reduce the burden of the diseases, and also to help better define and diagnose the diseases.

"The varied definitions of asthma and COPD around the world mean many people are not diagnosed or are incorrectly diagnosed. For this reason, we need much clearer understanding of how the diseases develop to help us identify cases more conclusively. The benefits of a simpler global definition of these diseases would mean more people were diagnosed, and could access the cheap and effective treatments that can prevent these avoidable deaths." explains Professor Vos. 

As a result of the varied definitions of COPD and asthma, and of varying data quality around the world, there is some uncertainty within the study's estimates.

Writing in a linked Comment, Professor Onno van Schayck, Maastricht University, the Netherlands, says: "To reduce the prevalence of COPD and asthma, interventions should focus on modifiable factors. In the case of COPD, interventions aimed at smoking cessation and reducing household air pollution are the most apparent. There have been numerous initiatives to reduce smoking worldwide, resulting in a decreased prevalence between 1990 and 2015. Now is the time to tackle ambient and household air pollution, which together cause more DALYs than smoking alone. The use of biomass fuel is one of the greatest causes of air pollution. Nowadays, more than half of the world's population uses biomass fuel as a primary cooking source, resulting in a high burden of morbidity and mortality. To reduce household air pollution, a switch to cleaner fuels would be desirable. However, this change is not always possible due to financial or logistical constraints, especially in urban slums. It is estimated that 1*8 billion people will still be reliant on solid biomass for cooking in 2040. Consequently, interventions should also aim to include the development of low-smoke biomass cooking stoves. The GBD study reports the global burden of COPD and asthma and stresses the need for good policy making."


Story Source:

Materials provided by The Lancet. Note: Content may be edited for style and length.


Journal Reference:

  1. Joan B Soriano, Amanuel Alemu Abajobir, Kalkidan Hassen Abate, Semaw Ferede Abera, Anurag Agrawal, Muktar Beshir Ahmed, Amani Nidhal Aichour, Ibtihel Aichour, Miloud Taki Eddine Aichour, Khurshid Alam, Noore Alam, Juma M Alkaabi, Fatma Al-Maskari, Nelson Alvis-Guzman, Alemayehu Amberbir, Yaw Ampem Amoako, Mustafa Geleto Ansha, Josep M Antó, Hamid Asayesh, Tesfay Mehari Atey, Euripide Frinel G Arthur Avokpaho, Aleksandra Barac, Sanjay Basu, Neeraj Bedi, Isabela M Bensenor, Adugnaw Berhane, Addisu Shunu Beyene, Zulfiqar A Bhutta, Stan Biryukov, Dube Jara Boneya, Michael Brauer, David O Carpenter, Daniel Casey, Devasahayam Jesudas Christopher, Lalit Dandona, Rakhi Dandona, Samath D Dharmaratne, Huyen Phuc Do, Florian Fischer, Ayele Geleto, Aloke Gopal Ghoshal, Richard F Gillum, Ibrahim Abdelmageem Mohamed Ginawi, Vipin Gupta, Simon I Hay, Mohammad T Hedayati, Nobuyuki Horita, H Dean Hosgood, Mihajlo (Michael) B Jakovljevic, Spencer Lewis James, Jost B Jonas, Amir Kasaeian, Yousef Saleh Khader, Ibrahim A Khalil, Ejaz Ahmad Khan, Young-Ho Khang, Jagdish Khubchandani, Luke D Knibbs, Soewarta Kosen, Parvaiz A Koul, G Anil Kumar, Cheru Tesema Leshargie, Xiaofeng Liang, Hassan Magdy Abd El Razek, Azeem Majeed, Deborah Carvalho Malta, Treh Manhertz, Neal Marquez, Alem Mehari, George A Mensah, Ted R Miller, Karzan Abdulmuhsin Mohammad, Kedir Endris Mohammed, Shafiu Mohammed, Ali H Mokdad, Mohsen Naghavi, Cuong Tat Nguyen, Grant Nguyen, Quyen Le Nguyen, Trang Huyen Nguyen, Dina Nur Anggraini Ningrum, Vuong Minh Nong, Jennifer Ifeoma Obi, Yewande E Odeyemi, Felix Akpojene Ogbo, Eyal Oren, Mahesh PA, Eun-Kee Park, George C Patton, Katherine Paulson, Mostafa Qorbani, Reginald Quansah, Anwar Rafay, Mohammad Hifz Ur Rahman, Rajesh Kumar Rai, Salman Rawaf, Nik Reinig, Saeid Safiri, Rodrigo Sarmiento-Suarez, Benn Sartorius, Miloje Savic, Monika Sawhney, Mika Shigematsu, Mari Smith, Fentaw Tadese, George D Thurston, Roman Topor-Madry, Bach Xuan Tran, Kingsley Nnanna Ukwaja, Job F M van Boven, Vasiliy Victorovich Vlassov, Stein Emil Vollset, Xia Wan, Andrea Werdecker, Sarah Wulf Hanson, Yuichiro Yano, Hassen Hamid Yimam, Naohiro Yonemoto, Chuanhua Yu, Zoubida Zaidi, Maysaa El Sayed Zaki, Christopher J L Murray, Theo Vos. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine, 2017; DOI: 10.1016/S2213-2600(17)30293-X

Cite This Page:

The Lancet. "Chronic obstructive pulmonary disease caused 3.2 million deaths worldwide in 2015." ScienceDaily. ScienceDaily, 16 August 2017. <www.sciencedaily.com/releases/2017/08/170816221606.htm>.
The Lancet. (2017, August 16). Chronic obstructive pulmonary disease caused 3.2 million deaths worldwide in 2015. ScienceDaily. Retrieved November 29, 2024 from www.sciencedaily.com/releases/2017/08/170816221606.htm
The Lancet. "Chronic obstructive pulmonary disease caused 3.2 million deaths worldwide in 2015." ScienceDaily. www.sciencedaily.com/releases/2017/08/170816221606.htm (accessed November 29, 2024).

Explore More

from ScienceDaily

RELATED STORIES